Clinical Trials for Amneal Pharmaceuticals

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Amneal Pharmaceuticals

Clinical Trials (6)

NCT07138560
BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease
PHASE4Recruiting
22 participants
Started: Jul 24, 2025 · Completed: May 15, 2027
1 condition2 sponsors1 location
NCT06765668
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
PHASE4Recruiting
220 participants
Started: Feb 12, 2025 · Completed: Aug 6, 2026
1 condition2 sponsors27 locations
NCT06267274
A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
PHASE1Recruiting
240 participants
Started: Apr 1, 2024 · Completed: May 1, 2025
2 conditions3 sponsors4 locations
NCT05401357
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
PHASE3Recruiting
168 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2022
2 conditions2 sponsors9 locations
NCT01733082
The Mycophenolate Pregnancy Registry
N/ARecruiting
500 participants
Started: Nov 20, 2012 · Completed: Dec 31, 2025
1 condition29 sponsors1 location
NCT00404989
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
N/ARecruiting
24,258 participants
Started: Jan 31, 1989 · Completed: Jan 31, 2099
2 conditions28 sponsors1 location